Dublin, April 19, 2024 (GLOBE NEWSWIRE) — The “RNA Analysis Market – Global Industry Size, Share, Trends, Opportunities and Forecast 2018-2028” report has been added to ResearchAndMarkets.com Dedication.
The global RNA analysis market is showing strong growth momentum, with the market valuation expected to increase to US$7.45 billion in 2022, and is expected to maintain a stable growth trajectory from 2018 to 2028. expansion.
As a core part of molecular biology and genomics, RNA analysis provides valuable insights into the structure, function, and regulatory mechanisms of RNA molecules. The industry is growing at a CAGR of 9%, driven by technological innovations in next-generation sequencing (NGS) and single-cell RNA sequencing (scRNA-seq), which improve the accuracy and reduce costs of RNA-based examinations.
Advances in RNA sequencing drive global market growth
Groundbreaking improvements to platforms such as Illumina’s HiSeq and NovaSeq have enhanced the capabilities of RNA-Seq, allowing researchers to analyze large numbers of RNA molecules. At the same time, long-read sequencing technologies such as SMRT sequencing and nanopore sequencing have become key tools for studying complex gene structures and alternative splicing events. Progress in the field is also reflected in the increasing proliferation of sample preparation technologies that allow RNA analysis from scarce resources such as clinical biopsies. This versatility is key to driving the widespread use of RNA analysis in fields ranging from agriculture to personalized medicine.
Cutting Edge: RNA Analysis in Oncology and Agriculture
In the field of oncology research, RNA analysis is critical for identifying cancer biomarkers and facilitating the development of targeted therapies. The critical need for these sophisticated diagnostic tools is underpinned by the urgent need to address the growing global prevalence of cancer. Likewise, in agriculture, RNA analysis is key to uncovering genes that contribute to traits such as disease resistance and drought tolerance, thereby supporting the evolution of stress-tolerant crop varieties. This important application in enhancing food security is a strong driver of the global RNA analysis market.
Single-cell RNA sequencing challenges hinder market progress
Despite strong expansion, the complexity of single-cell RNA sequencing poses significant challenges, from managing high-dimensional data to maintaining sample quality. Overcoming these barriers is critical to realizing the full potential of RNA analysis in scientific discovery and clinical applications.
Bioinformatics and Data Analysis: The Pulse of RNA Analysis
The large amount of RNA-Seq data emphasizes the necessity of sophisticated bioinformatics tools for data preprocessing and quality control. Enhanced algorithms are critical for combating large amounts of genetic information, facilitating alignment, annotation, and interpretation of RNA-Seq data to gain actionable insights.
Kits and reagents and qPCR technology dominate
In the product segment, kits and reagents maintain their dominance, favored by research laboratories for their standardization and reliability. Likewise, the field of qPCR is known for its precision and versatility, leading the technological frontier and underpinning countless RNA analysis operations, including pathogen detection and microRNA analysis.
Infectious diseases drive market demand
In line with pressing global health challenges, the infectious diseases and pathogenesis segment has emerged as a significant market contributor. The ongoing management of epidemics such as COVID-19 has highlighted the critical role played by RNA analysis in monitoring and mitigating infectious disease threats, thereby underpinning the market trajectory.
Leading market share in North America
With strong scientific research infrastructure and active pharmaceutical industry, North America is a preeminent region for the global RNA analysis market. The region’s popularity is attributed to a combination of technological prowess, substantial research funding, and a comprehensive regulatory environment that promotes RNA-based research.
Key attributes
| Report properties | detail |
| Number of pages | 180 |
| forecast period | 2022-2028 |
| Estimated market value in 2022 (USD) | $7.45 billion |
| Forecast market value by 2028 (USD) | $12.45 billion |
| CAGR | 9% |
| Coverage area | Global |
Some of the companies mentioned in this report include, but are not limited to:
- Agilent Technologies
- F.Hofmann-La Roche AG
- lighting company
- QJ
- Thermo Fisher Scientific
- Continental Technology
- Merck
- Bio-Rad Laboratories Ltd.
- California Pacific Biosciences
- Affymetrix Corporation
For more information about this report, please visit https://www.researchandmarkets.com/r/msd4co
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and latest trends.
-
Global RNA Analysis Market
#Global #RNA #Analysis #Market #Forecast #Increasing #RNASeq #data #volume #spurs #demand #advanced #bioinformatics #tools #enhanced #algorithms #key #leveraging #genetic #insights
Image Source : www.globenewswire.com